CERECOR INC has a total of 35 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are VALEANT PHARMACEUTICALS NORTH, ELIAZ ISAAC and GLAXO WELLCOME LAB SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | Mexico | 2 | |
#9 | Taiwan | 2 | |
#10 | Argentina | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Sugars | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Mezaache Djelila | 14 |
#2 | Mazhari Reza | 14 |
#3 | Garner Rachel M | 11 |
#4 | Vornov James | 11 |
#5 | Paterson Blake M | 11 |
#6 | Nelson Todd | 10 |
#7 | Pertusati Fabrizio | 6 |
#8 | Thomas Stephen B | 6 |
#9 | Paterson Blake | 6 |
#10 | Crutcher Patrick J | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020191052A1 | Methods for treating symptomatic orthostatic hypotension | |
EP3735251A1 | Nucleotide prodrugs | |
WO2019118486A1 | Monosaccharide phosphoramidate prodrugs | |
US2018346508A1 | Nucleic acid prodrugs | |
CN107108560A | Compound, composition and its method | |
EP2838595A1 | Nhalation devices and systems | |
US2013274342A1 | Compositions and methods for treating cough |